FOXP3 and neoplasm: In addition, non-statistically significant differences were seen in the frequency of CD4+FoxP3+ T cells and CD11b+Ly6G+ cells in the tumours of pHIFU + ICI-treated subjects compared with controls 48 h after treatment.